Posted on 12th February, 2020
by Legal Staff
Mounting evidence suggests that exposure to Monsanto's Roundup weed killer increases the risk of developing non-Hodgkin's lymphoma, a form of cancer that originates in the lymphatic system.
We aim to inform readers about this disease and raise awareness about it so that people will remain safe.
Non-Hodgkin's lymphoma, also known as Lymphoma or just NHL, is a type of cancer that starts in the lymphocytes, which are the white blood cells and are responsible for proper functioning of the body's immune system. In this type of cancer, some of the white blood cells divide abnormally. The white blood cells have been designed to have a resting time, but in people who have lymphoma, some of these cells divide continuously and so their number is higher than usual.
Because they start dividing before they reach maturity, they cannot effectively fight infection. These abnormal white blood cells start collecting in the lymph nodes, the spleen, the bone marrow or other organs growing into tumors.
Each non-Hodgkin's lymphoma is assigned a stage depending on how serious the disease is. This helps the doctor determine the treatment options and prognosis.
NHL has many symptoms and signs, depending on the stage of the disease and its location, but sometimes there might be no symptoms until the tumor grows quite large. Many of the signs might even be confused with other diseases and affections, such as an infection. Only after a thorough check, the doctor will be able to give a correct diagnostic.
Some common symptoms of NHL include:
Non-Hodgkin Lymphoma does not have a specific cause but doctors believe that a weakened immune system plays an important role.
Still, there are some risk factors that can be taken into consideration:
The treatment for non-Hodgkin Lymphoma depends on the nature of the disease. For this the doctor has to determine what type of lymphocyte has been affected (B Cells or T Cells) and how fast the lymphomas grow and spread (indolent or aggressive).
Unfortunately, some types of lymphoma, such as mantle cell lymphoma, do not fit neatly into either of these categories.
If the Non-Hodgkin Lymphoma causes symptoms and signs or is the aggressive type, the treatment will include one or several of the following:
Chemotherapy is a drug treatment that is injected or given orally. Its aim is to kill cancer cells and the side effects depend on the type of drugs given. The patient might experience hair loss and nausea, but also lung damage, heart damage, fertility problems or even leukemia.
During radiation therapy, high-powered energy beams (protons and X-rays) are used to kill cancer cells. During this procedure, the patient will be positioned on a table, while the machine will direct the radiation beams at precise points on the body, such as the affected lymph nodes and the surrounding area where the disease might progress. The typical radiation treatment includes hospital visits to the hospital five days per week for a few weeks, with a radiation session of 30 minutes.
Side effects of radiation therapy include hair loss in the area where the radiation is aimed, skin redness, fatigue, but also heart disease, thyroid problems, stroke, infertility or even breast or lung cancer.
Bone marrow transplant (stem cell transplant) is another treatment option. First, the patient has to undergo high doses of radiation therapy or chemotherapy to suppress the bone marrow. Then healthy bone marrow stem cells will be harvested from the patient or a donor and then infused back into the body and start rebuilding new bone marrow.
Biological therapy can also be used to help the body's immune system fight the disease. Rituximab (Rituxan) is a monoclonal antibody which attaches to the B Cells making them more visible to the immune system. Although the antibody lowers the number of B cells, it forces the body to produce new healthy ones to replace them. This makes the cancerous B cells less likely to occur.
Some doctors prescribe Radioimmunotherapy drugs which are made of monoclonal antibodies. They carry radioactive isotopes which allow the antibody to attach to cancer cells and deliver radiation directly to the cells. An example of a radioimmunotherapy drug used to treat non-Hodgkin's lymphoma is ibritumomab tiuxetan (Zevalin).
After completing your treatment for Non-Hodgkin Lymphoma, you should still see your doctor on a regular basis and have tests done to check for signs for cancer recurrence or developing new cancer. People who suffered from Non-Hodgkin Lymphoma have an increased risk of developing other types of cancer such as lung cancer, melanoma skin cancer, kidney cancer, colon cancer, bladder cancer, thyroid cancer, leukemia, Hodgkin disease, bone cancer or cancers of the neck and head.
Women who had treatment with chest radiation before the age of 30 are at risk of developing breast cancer. The American Cancer Society recommends these women yearly breast MRI, mammograms and breast exams.
Some people might never get their NHL completely cured. For them, it is imperative to get regular treatments with radiation, chemo or other therapies to keep the lymphoma under control and to relieve the symptoms. Your doctor will perform blood tests and imaging tests such as CT scans or PET/CT.
The best way to detect Non-Hodgkin Lymphoma in its early stage is to pay attention to the symptoms, especially a bump or lump under the skin, usually in the armpit, in the groin or on the side of the neck. Having regular check-ups is of utmost importance for people with risk factors, such as HIV infection, autoimmune disease, organ transplant or prior cancer treatment.
Glyphosate-based herbicides inhibit a specific enzyme called EPSP synthase that plants need in order to grow. Without EPSP synthase, plants are unable to produce proteins essential to growth, so they die over the course of several days. Glyphosate annihilate plants like antibiotics annihilate bacteria.
Is glyphosate likely to contribute to cancer development? To this question, the jury says "yes". A California jury ordered the Monsanto Co. to pay $289 million to the former school groundskeeper diagnosed with non-Hodgkin's lymphoma.
In 2015, the World Health Organisation's cancer agency asserts that glyphosate is "probably carcinogenic" to humans. Some countries such as Portugal, Italy and the Canadian city of Vancouver, have banned glyphosate use in public parks and gardens.
A broad new scientific analysis of the cancer-causing potential of glyphosate herbicides has found that exposure to the most widely used broad-spectrum systemic herbicide in the world, increases the risk of developing non-Hodgkin's lymphoma by 41 percent. The study found that the type of herbicide used influenced cancer risk, and the researchers also suggested that the active ingredients in the herbicide, too, could influence the development of cancer - and the active ingredients used may also be associated with specific cancer subtypes.
Glyphosate usage has increased considerably in the years since studies collected their exposure data, so studies done now could include higher exposures and more exposed individuals, possibly leading to stronger conclusions.
New studies proved that Roundup, with its active ingredient glyphosate, is more toxic than declared.
Individuals who have developed non-Hodgkin's lymphoma or other condition and previously have worked with glyphosate extensively stepped forward and began to claim their rights.
If you or a family member have been diagnosed with non-Hodgkin's lymphoma under suspicion of exposure to glyphosate-containing products, don't hesitate to contact us in order to discuss your options regarding fair compensation for your pain and suffering.